QuidelOrtho Strengthens Leadership with Global Quality and Clinical Affairs Appointments.

QuidelOrtho Corporation has appointed two executives to its leadership team: Devon Burek as Senior Vice President of Global Quality and Sergio Gadaleta as Senior Vice President of Clinical and Regulatory Affairs. Burek and Gadaleta bring deep expertise in quality and regulatory affairs, respectively, to elevate product quality and accelerate innovation across global operations. Their hires reflect the Company's continued investment in operational excellence and regulatory innovation to support global growth.

QuidelOrtho Corporation (NASDAQ: QDEL) has bolstered its leadership team with the appointment of Devon Burek as Senior Vice President of Global Quality and Sergio Gadaleta as Senior Vice President of Clinical and Regulatory Affairs. These appointments reflect the company's ongoing commitment to operational excellence and regulatory innovation, crucial for supporting its global growth.

Devon Burek, who brings over two decades of experience from Roche, will oversee QuidelOrtho's global quality organization, focusing on streamlining quality approaches and enhancing operational effectiveness. Prior to joining QuidelOrtho, Burek held various quality leadership roles across diagnostics and R&D at Roche. Her expertise will be instrumental in driving long-term impact and ensuring high-quality products and solutions for the company's customers [1].

Sergio Gadaleta, who holds a PhD in chemistry, will lead QuidelOrtho's global clinical trial strategy and regulatory submissions. His extensive experience spans senior roles at BD, 3M, Johnson & Johnson, and the FDA. Gadaleta's strategic mindset and scientific rigor will guide the company's innovations through complex global regulations, ensuring they reach healthcare providers worldwide [2].

These appointments underscore QuidelOrtho's dedication to building a high-performance organization rooted in scientific excellence and customer trust. The company's commitment to advancing diagnostics is evident in its mission to power a healthier future through innovative in vitro diagnostic technologies.

References:

[1] https://www.stocktitan.net/news/QDEL/quidel-ortho-strengthens-leadership-team-with-appointments-of-senior-sfkyzd1hmbua.html

[2] https://www.prnewswire.com/news-releases/quidelortho-strengthens-leadership-team-with-appointments-of-senior-vice-presidents-for-global-quality-and-clinical--regulatory-affairs-302498733.html